Stay updated on Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Sign up to get notified when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.

Latest updates to the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page
- CheckyesterdayChange DetectedThe record history now shows Revision: v3.5.2 added and Revision: v3.5.0 removed.SummaryDifference0.1%

- Check8 days agoChange DetectedThe new screenshot shows updated version entries in the record history, reflecting changes to study status, design, and related fields over time.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.5.0 was added to the history, and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check36 days agoChange DetectedAdded Revision: v3.4.3 to the history. Removed Revision: v3.4.2 from the history.SummaryDifference0.1%

- Check44 days agoChange DetectedThe history shows updates to the study record across versions, including changes to Study Status, Recruitment Status, and sections such as Outcome Measures and Eligibility. It also highlights QC/Quality Control Review status across versions.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior funding notice (lapse in government funding) and the older Revision: v3.4.1 from the page.SummaryDifference0.7%

Stay in the know with updates to Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.